Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Influence of donor and recipient genotypes on CYP2D6 phenotype after liver transplantation: a study of mutations CYP2D63 and CYP2D64.

European journal of clinical pharmacology - 1 Mar 1998

Monek O, Paintaud G, Bechtel Y, Miguet J P, Mantion G, Bechtel P R

Abstract excerpt

OBJECTIVE: After liver transplantation (LT), genotypic differences between the recipient and the transplanted liver, medications and post-LT complications may all affect drug metabolism. We have studied the effect of two CYP2D6 mutations in the donor and the recipient on post-LT CYP2D6 phenotype. METHOD: The CYP2D6 phenotype was assessed in 48 patients before and after LT with debrisoquine or dextromethorphan....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Cytochrome P-450 CYP2D6

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Debrisoquin

Share to Dextromethorphan

Share to Genotype

Share to Liver Transplantation

Share to Mutation

Share to Phenotype

Source

Identifiers

PMID: 9591930
DOI: 10.1007/s002280050419

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Influence of donor and recipient genotypes on CYP2D6 phenotype after liver transplantation: a study of mutations CYP2D6*3 and CYP2D6*4.PMID 9591930Read ↗

Stability of debrisoquine (CYP2D6) phenotype in liver transplant patients.Semantic proximity Read ↗

The recipient CYP2D6 allele 4-associated poor metabolizer status correlates with an early fibrosis development after liver transplantation.Semantic proximity Read ↗

Correlation between cytochrome P-450 CYP2D6 (CYP2D6) genotype and phenotype.Semantic proximity Read ↗

Drug-induced liver graft toxicity caused by cytochrome P450 poor metabolism.Semantic proximity Read ↗

Identification of a new variant CYP2D6 allele with a single base deletion in exon 3 and its association with the poor metabolizer phenotype.Semantic proximity Read ↗

Coordinated intrahepatic and extrahepatic regulation of cytochrome p4502D6 in healthy subjects and in patients after liver transplantation.Semantic proximity Read ↗

New cytochrome P450 2D6*56 allele identified by genotype/phenotype analysis of cryopreserved human hepatocytes.Semantic proximity Read ↗

[Genetic polymorphism of drug metabolizing enzymes: new mutations in CYP2D6 and CYP2A6 genes in Japanese].Semantic proximity Read ↗

Multiple mutations of the human cytochrome P450IID6 gene (CYP2D6) in poor metabolizers of debrisoquine. Study of the functional significance of individual mutations by expression of chimeric genes.Semantic proximity Read ↗

Determination of debrisoquine and 4-hydroxydebrisoquine by high-performance liquid chromatography: application to the evaluation of CYP2D6 genotype and debrisoquine metabolic ratio relationship.Semantic proximity Read ↗

Identification of a new variant CYP2D6 allele lacking the codon encoding Lys-281: possible association with the poor metabolizer phenotype.Semantic proximity Read ↗

Influence of the CYP2D6*10 allele on the metabolism of mexiletine by human liver microsomes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.